- Home
- INVE vs GNLX Comparison
INVE vs GNLX Comparison
Compare INVE & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVE
- GNLX
- Stock Information
- Founded
- INVE 1990
- GNLX 2001
- Country
- INVE United States
- GNLX United States
- Employees
- INVE N/A
- GNLX N/A
- Industry
- INVE Computer peripheral equipment
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- INVE Technology
- GNLX Health Care
- Exchange
- INVE Nasdaq
- GNLX Nasdaq
- Market Cap
- INVE 86.5M
- GNLX 85.0M
- IPO Year
- INVE 1997
- GNLX 2023
- Fundamental
- Price
- INVE $3.53
- GNLX $5.45
- Analyst Decision
- INVE Strong Buy
- GNLX Strong Buy
- Analyst Count
- INVE 2
- GNLX 4
- Target Price
- INVE $7.25
- GNLX $18.25
- AVG Volume (30 Days)
- INVE 34.6K
- GNLX 382.1K
- Earning Date
- INVE 03-11-2025
- GNLX 03-31-2025
- Dividend Yield
- INVE N/A
- GNLX N/A
- EPS Growth
- INVE N/A
- GNLX N/A
- EPS
- INVE 3.10
- GNLX N/A
- Revenue
- INVE $104,217,000.00
- GNLX $8,000.00
- Revenue This Year
- INVE N/A
- GNLX N/A
- Revenue Next Year
- INVE N/A
- GNLX N/A
- P/E Ratio
- INVE $1.13
- GNLX N/A
- Revenue Growth
- INVE 70.57
- GNLX N/A
- 52 Week Low
- INVE $2.95
- GNLX $1.60
- 52 Week High
- INVE $9.24
- GNLX $8.67
- Technical
- Relative Strength Index (RSI)
- INVE 46.25
- GNLX 76.55
- Support Level
- INVE $3.41
- GNLX $5.30
- Resistance Level
- INVE $3.67
- GNLX $5.89
- Average True Range (ATR)
- INVE 0.18
- GNLX 0.52
- MACD
- INVE 0.01
- GNLX 0.15
- Stochastic Oscillator
- INVE 34.88
- GNLX 88.08
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.